Aimee Weisner
Direktor/Vorstandsmitglied bei GLAUKOS CORPORATION
Vermögen: 4 Mio $ am 30.04.2024
Aktive Positionen von Aimee Weisner
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GLAUKOS CORPORATION | Direktor/Vorstandsmitglied | 01.07.2014 | - |
Independent Dir/Board Member | 01.07.2014 | - | |
LENSAR, INC. | Direktor/Vorstandsmitglied | 01.02.2021 | - |
Independent Dir/Board Member | 01.02.2021 | - | |
STAAR SURGICAL COMPANY | Direktor/Vorstandsmitglied | 16.06.2022 | - |
Independent Dir/Board Member | 16.06.2022 | - | |
NeuroSigma, Inc.
NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA. | Direktor/Vorstandsmitglied | 01.01.2014 | - |
American Heart Association of Orange County | Direktor/Vorstandsmitglied | 01.01.2017 | - |
Vorsitzender | 01.01.2015 | 01.01.2017 |
Karriereverlauf von Aimee Weisner
Ehemalige bekannte Positionen von Aimee Weisner
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
OYSR POIN | Direktor/Vorstandsmitglied | 30.10.2019 | 03.01.2023 |
Independent Dir/Board Member | 30.10.2019 | 03.01.2023 | |
EDWARDS LIFESCIENCES CORPORATION | General Counsel | 13.01.2011 | 01.07.2019 |
Advanced Medical Optics, Inc.
Advanced Medical Optics, Inc. Medical SpecialtiesHealth Technology Advanced Medical Optics, Inc. manufactures intraocular lens and optical medical devices for eye disorders. Its products includes intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery. It develops sovereign system, which is equipped with WhiteStar software that uses ultrasound power to dissolve dense cataracts that can develop in the eye, Amadeus microkeratome, a device used during LASIK procedures and Verisyse phakic IOL for treatment of moderate to severe myopia. It was founded in 1976 Santa Ana, CA. | Verwaltungsdirektor | 01.01.2002 | 01.01.2009 |
General Counsel | 01.01.2002 | 01.01.2009 | |
Unternehmenssekretär | 01.01.2002 | 01.01.2009 | |
ALLERGAN, INC. | General Counsel | - | - |
Corporate Officer/Principal | 01.01.1998 | 01.06.2002 | |
░░░░░░░░░ ░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Aimee Weisner
Loyola Law School | Graduate Degree |
California State University-Fullerton | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 14 |
Operativ
Director/Board Member | 7 |
Independent Dir/Board Member | 4 |
General Counsel | 3 |
Sektoral
Health Technology | 9 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
EDWARDS LIFESCIENCES CORPORATION | Health Technology |
GLAUKOS CORPORATION | Health Technology |
LENSAR, INC. | Health Technology |
STAAR SURGICAL COMPANY | Health Technology |
Private Unternehmen | 7 |
---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
O'Melveny & Myers LLP
O'Melveny & Myers LLP Miscellaneous Commercial ServicesCommercial Services O'Melveny & Myers LLP provides legal services. Its practice areas include labor and employment, litigation, tax, and transactions. The firm serves high-tech companies in the areas of legal advice related to software licensing, intellectual property, and venture capital investments. The company was founded by Henry William O'Melveny in 1885 and is headquartered in Los Angeles. CA. | Commercial Services |
Advanced Medical Optics, Inc.
Advanced Medical Optics, Inc. Medical SpecialtiesHealth Technology Advanced Medical Optics, Inc. manufactures intraocular lens and optical medical devices for eye disorders. Its products includes intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery. It develops sovereign system, which is equipped with WhiteStar software that uses ultrasound power to dissolve dense cataracts that can develop in the eye, Amadeus microkeratome, a device used during LASIK procedures and Verisyse phakic IOL for treatment of moderate to severe myopia. It was founded in 1976 Santa Ana, CA. | Health Technology |
NeuroSigma, Inc.
NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA. | Health Technology |
American Heart Association of Orange County | |
Oyster Point Pharma, Inc.
Oyster Point Pharma, Inc. Pharmaceuticals: MajorHealth Technology Oyster Point Pharma, Inc. engages in the development and commercialization of pharmaceutical therapies to treat ocular surface diseases. Its product candidate, OC-01, is a nicotinic acetylcholine receptor agonist, which is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. The company was founded by Michael and is Ackermann in June 30, 2015 headquartered in Princeton, NJ. | Health Technology |
Avellino Labs USA, Inc.
Avellino Labs USA, Inc. Medical/Nursing ServicesHealth Services Avellino Lab USA, Inc. engages in the provision of diagnostic testing services. It focuses on developing genetic tests for eye care professionals. It also involves in research and development activities related to genetic diagnostics for the prediction and prevention of eye conditions. The company was founded by Gene Lee in 2008 and is headquartered in Menlo Park, CA. | Health Services |
- Börse
- Insiders
- Aimee Weisner
- Erfahrung